DGAP-Ad-hoc: Merck KGaA / Key word(s): Forecast/Change in Forecast
Darmstadt, 4 May 2021. Based on high demand expected to continue throughout the year and a very strong first quarter of 2021 with net sales of EUR 4.63 bn resulting in EBITDA pre1 of EUR 1.51 bn and EPS pre1 of EUR 2.18, Merck KGaA (the "Company") has raised its forecast for the entire group for fiscal 2021. The Company now projects net sales of approx. EUR 18.5 - 19.5 bn (previously "strong organic growth"). EBITDA pre1 is anticipated to grow to approx. EUR 5.4 - 5.8 bn for the group (previously "organic: high single-digit to low teens growth"). EPS pre1 is projected to amount to approx. EUR 7.50 - 8.20.
The Company will publish first-quarter 2021 figures as scheduled on 12 May 2021.
1 EBITDA pre and EPS pre are alternative performance measures not defined by international accounting standards, used by the Company to improve the comparability of business performance over time and within the industry. EBITDA pre means earnings before interest, income tax, depreciation and amortization as well as adjustments (Ergebnis vor Zinsen, Ertragsteuern, Abschreibungen und Anpassungen). EPS pre means profit after tax including adjustments per theoretical shares outstanding (see Merck Annual Report 2020).
Andreas Cezanne, Head of Corporate Media Relations
04-May-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Frankfurter Str. 250|
|Phone:||+49 (0)6151 72 - 2702|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX|
|EQS News ID:||1192510|
|End of Announcement||DGAP News Service|
1192510 04-May-2021 CET/CEST